Dongwha Pharm.Co.Ltd (000020) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.024x

Based on the latest financial reports, Dongwha Pharm.Co.Ltd (000020) has a cash flow conversion efficiency ratio of 0.024x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩9.70 Billion ≈ $6.57 Million USD) by net assets (₩401.44 Billion ≈ $272.05 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Dongwha Pharm.Co.Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Dongwha Pharm.Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Dongwha Pharm.Co.Ltd (000020) total liabilities for a breakdown of total debt and financial obligations.

Dongwha Pharm.Co.Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Dongwha Pharm.Co.Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Bridger Aerospace Group Holdings, Inc. Common Stock NASDAQ:BAER	0.526x
Bcl Industries Limited NSE:BCLIND	0.021x
ELEMENT 29 RESOURCES INC F:2IK	N/A
Procaps Group SA NASDAQ:PROC	1.232x
Diploma PLC LSE:DPLM	0.174x
Celik Halat ve Tel Sanayi AS IS:CELHA	-0.023x
Calitech Co Ltd TWO:6532	0.028x
Waldencast Acquisition Corp NASDAQ:WALD	-0.003x

Annual Cash Flow Conversion Efficiency for Dongwha Pharm.Co.Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Dongwha Pharm.Co.Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see 000020 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩401.44 Billion ≈ $272.05 Million	₩15.70 Billion ≈ $10.64 Million	0.039x	+492.38%
2024-12-31	₩401.68 Billion ≈ $272.21 Million	₩-4.00 Billion ≈ $-2.71 Million	-0.010x	-113.91%
2023-12-31	₩407.06 Billion ≈ $275.86 Million	₩29.17 Billion ≈ $19.77 Million	0.072x	-7.15%
2022-12-31	₩378.67 Billion ≈ $256.62 Million	₩29.22 Billion ≈ $19.80 Million	0.077x	-22.87%
2021-12-31	₩360.13 Billion ≈ $244.06 Million	₩36.03 Billion ≈ $24.42 Million	0.100x	-34.35%
2020-12-31	₩342.68 Billion ≈ $232.23 Million	₩52.23 Billion ≈ $35.39 Million	0.152x	+245.17%
2019-12-31	₩300.87 Billion ≈ $203.90 Million	₩13.28 Billion ≈ $9.00 Million	0.044x	+401.18%
2018-12-31	₩297.40 Billion ≈ $201.54 Million	₩-4.36 Billion ≈ $-2.95 Million	-0.015x	+73.65%
2017-12-31	₩296.94 Billion ≈ $201.24 Million	₩-16.52 Billion ≈ $-11.20 Million	-0.056x	-155.22%
2016-12-31	₩252.93 Billion ≈ $171.40 Million	₩25.48 Billion ≈ $17.27 Million	0.101x	+16.90%
2015-12-31	₩230.12 Billion ≈ $155.95 Million	₩19.83 Billion ≈ $13.44 Million	0.086x	+46.50%
2014-12-31	₩229.73 Billion ≈ $155.68 Million	₩13.51 Billion ≈ $9.16 Million	0.059x	+62.92%
2013-12-31	₩227.23 Billion ≈ $153.99 Million	₩8.21 Billion ≈ $5.56 Million	0.036x	-67.51%
2012-12-31	₩226.99 Billion ≈ $153.83 Million	₩25.23 Billion ≈ $17.10 Million	0.111x	-44.82%
2011-12-31	₩229.62 Billion ≈ $155.61 Million	₩46.24 Billion ≈ $31.34 Million	0.201x	--

About Dongwha Pharm.Co.Ltd

KO:000020 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$113.83 Million

₩167.97 Billion KRW

Market Cap Rank

#18692 Global

#968 in Korea

Share Price

₩6060.00

Change (1 day)

-0.49%

52-Week Range

₩5660.00 - ₩7060.00

All Time High

₩28554.43